Novo Holdings A/S 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-31 4:28 pm Sale | 2022-01-28 | 13D | Aligos Therapeutics, Inc. ALGS | Novo Holdings A/S | 78,000 4.900% | -26,583 (-25.42%) | Filing |
| 2021-06-21 4:30 pm Unchanged | 2021-06-17 | 13D | Aligos Therapeutics, Inc. ALGS | Novo Holdings A/S | 104,583 7.500% | 0 (Unchanged) | Filing |
| 2020-10-22 4:31 pm Purchase | 2020-10-15 | 13D | Aligos Therapeutics, Inc. ALGS | Novo Holdings A/S | 104,583 7.700% | 104,583 (New Position) | Filing |